Artículos del autor

solaci

Day 3

STICS: perioperative statins to prevent atrial fibrillation

The aim of this study was to test whether perioperative treatment with rosuvastatin 20 mg could prevent...
solaci -
Day 2

NONI: Inhaled nitric oxide to reduce reperfusion injury in myocardial infarction

Infarct size is an independent predictor of survival and ventricular function. Several alternatives have been tried to...
solaci -
Day 3

X-Vert: Rivaroxaban in patients with atrial fibrillation undergoing elective cardioversion

This study included 1504 patients with atrial fibrillation and indication for elective electrical cardioversion who were randomized...
solaci -
Day 2

ATLANTIC: administration of ticagrelor in the ambulance versus in the cath lab

The platelet P2Y12 receptor antagonist ticagrelor is shown to reduce the incidence of cardiovascular events when administered...
solaci -
Day 2

EUROECO: Safety and cost effectiveness of new home monitoring device

Home monitoring is essential in modern medicine, but the cost-benefit analysis is essential for patients, insurance companies,...
solaci -
Day 2

MITOCARE: TRO40303 intravenous infusion in the context of primary angioplasty

Prospective, multicenter, randomized, double-blind study evaluated intravenous infusion of TRO40303 versus placebo administered immediately before balloon dilation...
solaci -
Day 2

FAMOUS NSTEMI: FFR versus Angiography in non-ST segment elevation myocardial infarction

The benefit of myocardial revascularization (angioplasty or surgery) guided by fractional flow reserve (FFR) in the context...
solaci -
Day 2

CULPRIT: Complete revascularization versus culprit artery of infarct only

Current guidelines suggest treating only the culprit artery of myocardial infarction with ST-segment elevation. This prospective and...
solaci -